Literature DB >> 7781801

Neuroendocrine tumours in various organ systems in a ten-year period.

H Hauser1, G Wolf, S Uranüs, M Klimpfinger.   

Abstract

Neuroendocrine cells are present in various organ systems. These widely distributed cells as well as their histogenetically related tumours can produce various peptides and peptide hormones. From 1984 to 1993, 349 neuroendocrine tumours were found among 511,382 histological diagnoses at the Institute of Pathology of the Medical School of the Karl Franzens University in Graz. In 30% carcinoid of the appendix was diagnosed, in 16% carcinoid of the colorectum, in 9% carcinoid of the small intestine and in 2% duodenal carcinoid. Carcinoid of the stomach was detected in 14%. Seven of these cases showed microcarcinoidosis and five of them were combined with an adenocarcinoma. Carcinoid of the oesophagus was present in 1%, neuroendocrine pancreatic tumours in 6%. Neuroendocrine tumours of the bronchial system were found in 12%, medullary thyroid cancer in 5%. In 1% a Merkel-cell tumour was diagnosed. Other more rare localizations of neuroendocrine tumours were the uterus, ovary, breast, testes, epididymis, anal region and the upper respiratory tract.

Entities:  

Mesh:

Year:  1995        PMID: 7781801     DOI: 10.1016/s0748-7983(95)91624-5

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Zollinger-Ellison syndrome with fasting hypoglycaemia.

Authors:  D McNamara; T Lewis; C O'Moran
Journal:  J R Soc Med       Date:  1998-02       Impact factor: 5.344

2.  Anatomic, age, and sex distribution of colorectal cancer in a New York City Hispanic population.

Authors:  D Chattar-Cora; G D Onime; G F Coppa; I S Valentine; L Rivera
Journal:  J Natl Med Assoc       Date:  1998-01       Impact factor: 1.798

Review 3.  Genes involved in neuroendocrine tumor biology.

Authors:  Eva Hofsli
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

4.  [A rare case of a neuroendocrine carcinoma of the esophagus. Intermediate between a well-differentiated neuroendocrine carcinoma and a low-differentiated neuroendocrine carcinoma].

Authors:  T Gumprich; G Johnen; T Hummel; M Jaworska; I Schmitz; K-M Müller
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

5.  Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs.

Authors:  Renata D'Alpino Peixoto; Krista L Noonan; Peter Pavlovich; Hagen F Kennecke; Howard J Lim
Journal:  J Gastrointest Oncol       Date:  2014-08

Review 6.  Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis.

Authors:  Xin Yang; Yuan Yang; Zhilu Li; Chen Cheng; Ting Yang; Cheng Wang; Lin Liu; Shengchun Liu
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

7.  Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature.

Authors:  Xin Yang; Youde Cao; Chen Chen; Lin Liu; Cheng Wang; Shengchun Liu
Journal:  Onco Targets Ther       Date:  2017-01-18       Impact factor: 4.147

8.  Moderately differentiated neuroendocrine carcinoma of the larynx.

Authors:  Eun-Jae Chung; Seung-Kuk Baek; Soon-Young Kwon; Jung-Soo Woo; Kwang-Yoon Jung
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

Review 9.  Carcinoid tumour of the oesophagus: a systematic review.

Authors:  Mazaher Ramezani; Masoud Sadeghi
Journal:  Prz Gastroenterol       Date:  2018-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.